{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T20:58:22Z","timestamp":1780865902873,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31460684"],"award-info":[{"award-number":["31460684"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biopha.2026.119250","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T21:24:11Z","timestamp":1774560251000},"page":"119250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anticancer effects of salidroside on ovarian cancer carcinogenesis and molecular mechanism in mice"],"prefix":"10.1016","volume":"198","author":[{"given":"Wei","family":"Suocheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Linglong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao","family":"Jingshuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Kun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119250_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/bs.ircmb.2024.03.006","article-title":"Epigenetic regulation in ovarian cancer","volume":"387","author":"Huevu","year":"2024","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119250_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520968353","article-title":"Inhibitory effects of salidroside on MCF-7 breast cancer cells in vivo","volume":"48","author":"Sun","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.biopha.2026.119250_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fphar.2023.1257617","article-title":"The pharmacological mechanism of chaihu-jia-longgu-muli-tang for treating depression: integrated meta-analysis and network pharmacology analysis","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119250_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2025.106932","article-title":"Salidroside induces ferroptosis in breast cancer cells and enhances the anticancer effect of oxaliplatin","volume":"130","author":"Zhang","year":"2025","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.biopha.2026.119250_bib5","article-title":"Salidroside exerts anti-tumor effects in ovarian cancer by inhibiting STAT3\/c-Myc pathway-mediated glycolysis","volume":"25","author":"Yu","year":"2025","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.biopha.2026.119250_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.17305\/bb.2024.10867","article-title":"Salidroside exerts anti-tumor effects in ovarian cancer binhibiting STAT3\/c-Myc pathway-mediated glycolysis","volume":"25","author":"Yu","year":"2025","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.biopha.2026.119250_bib7","first-page":"391","article-title":"Research progress in the biosynthesis of salidroside","volume":"6","author":"Shuhan","year":"2025","journal-title":"Synth. Biol. J."},{"key":"10.1016\/j.biopha.2026.119250_bib8","article-title":"Exploring mechanobiology in SKOV3 and OVCAR3 ovarian cancer cells","volume":"52","author":"Favero","year":"2023","journal-title":"Eur. Biophys. Biophys. Lett."},{"key":"10.1016\/j.biopha.2026.119250_bib9","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1007\/s11010-024-05168-w","article-title":"Salidroside overcomes cisplatin resistance in ovarian cancer via the inhibition of CRNDE-mediated autophagy","volume":"480","author":"Yu","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2026.119250_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/CBM-220454","article-title":"Salidroside suppresses proliferation and migration in prostate cancer via the PI3K\/AKT pathway","volume":"38","author":"Liu","year":"2023","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.biopha.2026.119250_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s43032-024-01585-w","article-title":"ARID1A in Gynecologic Precancers and Cancers","volume":"31","author":"Morgan","year":"2024","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.biopha.2026.119250_bib12","article-title":"Transforming growth factor-\u00df in tumour development","volume":"19","author":"Trelford","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2026.119250_bib13","first-page":"22","article-title":"SMAD4 Feedback Activates The Canonical TGF-\u03b2 Family Signaling Pathways","author":"Du","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119250_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.devcel.2023.11.020","article-title":"Smad4 sequestered in SFPQ condensates prevents TGF-\u03b2 tumor-suppressive signaling","volume":"59","author":"Xiao","year":"2024","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biopha.2026.119250_bib15","article-title":"SMAD4 inhibits glycolysis in ovarian cancer through PI3K\/AKT\/HK2 signaling pathway by activating ARHGAP10","volume":"7","author":"Wu","year":"2024","journal-title":"Cancer Rep."},{"key":"10.1016\/j.biopha.2026.119250_bib16","article-title":"Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119250_bib17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2020.12.005","article-title":"Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer","volume":"160","author":"Banville","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2026.119250_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13048-025-01668-5","article-title":"Thrombospondin-1 induces CD8+ T cell exhaustion and immune suppression within the tumor microenvironment of ovarian cancer","volume":"18","author":"Liang","year":"2025","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.biopha.2026.119250_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/medicina59020205","article-title":"Circulating CD4+ Treg, CD8+ Treg, and CD3+ \u03b3\u03b4 T cell subpopulations in ovarian cancer","volume":"59","author":"Li","year":"2023","journal-title":"Medicina"},{"key":"10.1016\/j.biopha.2026.119250_bib20","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2174\/1871520619666190801094059","article-title":"Receptor binding inhibitor suppresses carcinogenesis of cervical cancer by depressing levels of FSHR and ER\u03b2 in mice","volume":"19","author":"Gong","year":"2019","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.biopha.2026.119250_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bspc.2020.102107","article-title":"FRBI suppresses carcinogenesis of uterine cancers by regulating expressions of FHIT, PTEN and ARID1A","volume":"62","author":"Bai","year":"2020","journal-title":"Biomed. Signal Process. Control"},{"key":"10.1016\/j.biopha.2026.119250_bib22","article-title":"Half-lantern cyclometalated platinum(II) complexes as potent anticancer agents: molecular docking, apoptosis, cell cycle analysis and cytotoxic activity evaluations","author":"Hajipour","year":"2021","journal-title":"Chem. J."},{"key":"10.1016\/j.biopha.2026.119250_bib23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.bbrc.2011.12.063","article-title":"Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo","volume":"417","author":"Lei","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119250_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/B978-0-323-95488-4.00099-1","article-title":"Ovarian cancer and the environment: rodent models","volume":"11","author":"Vanderhyden","year":"2026","journal-title":"Compr. Toxicol."},{"key":"10.1016\/j.biopha.2026.119250_bib25","first-page":"387","article-title":"Targeting ovarian cancer with IL-2 cytokine\/antibody complexes: a summary and recent advances","volume":"3","author":"Deng","year":"2024","journal-title":"J. Cell. Immunol."},{"key":"10.1016\/j.biopha.2026.119250_bib26","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.3390\/cancers16162840","article-title":"Ascites and Serum Interleukin-10 Levels as a Prognostic Tool for Ovarian Cancer Outcomes","volume":"16","author":"Guigue","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2026.119250_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111514","article-title":"Estimating pathological prognostic factors in epithelial ovarian cancers using apparent diffusion coefficients of functional tumor volume","volume":"176","author":"Zhang","year":"2024","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.biopha.2026.119250_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/1757-2215-6-63","article-title":"Tracking NF-\u03baB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model","author":"Wilson","year":"2013","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.biopha.2026.119250_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/5032875","article-title":"Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ER\\\\r \u03b1\\\\r in Mice","volume":"2018","author":"Lai","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2026.119250_bib30","doi-asserted-by":"crossref","DOI":"10.1080\/21691401.2019.1584566","article-title":"Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK\/ERK signal pathway","author":"Ren","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119250_bib31","first-page":"3","article-title":"Evaluation of phosphatase and tensin homologue (PTEN) expression in gastric cancer and its relationship with histopathological findings","volume":"57","author":"Yazdi","year":"2024","journal-title":"Rev. Esp. De. Patol."},{"key":"10.1016\/j.biopha.2026.119250_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2024.101002","article-title":"PTEN downregulation inhibits cell proliferation and induces apoptosis in ovarian cancer cells","volume":"35","author":"Shin","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.biopha.2026.119250_bib33","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.3390\/nu15173723","article-title":"In vitro evaluation of the potential for drug interactions by salidroside","volume":"15","author":"Kasprzyk","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2026.119250_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-022-01495-y","article-title":"circPTEN1, a circular RNA generated from PTEN, suppresses cancer progression through inhibition of TGF-\u00df\/Smad signaling","volume":"21","author":"Lin","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2026.119250_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111253","article-title":"Arid1a mutation suppresses TGF-\u03b2 signaling and induces holangiocarcinoma","volume":"40","author":"Guo","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2026.119250_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116907","article-title":"Environmentally relevant concentration PFNA promotes degradation of SMAD7 to drive progression of ovarian cancer via TGF-\u03b2\/SMADs signaling pathway","volume":"284","author":"Zhong","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.biopha.2026.119250_bib37","article-title":"ARID1A has prognostic value in acute myeloid leukemia and promotes cell proliferation via TGF-\u03b21\/SMAD3 signaling","volume":"23","author":"Ren","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.biopha.2026.119250_bib38","article-title":"Therapeutic potential of silica nanoparticles, cisplatin, and quercetin on ovarian cancer: in vivo model","volume":"174","author":"Saeed","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119250_bib39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41684-023-01314-x","article-title":"Comparing mouse models of ovarian cancer","volume":"53","author":"Bras","year":"2024","journal-title":"Lab Anim."},{"key":"10.1016\/j.biopha.2026.119250_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-024-01157-8","article-title":"Imaging tumor and ascites-associated macrophages in a mouse model of metastatic ovarian cancer","volume":"14","author":"Foss","year":"2024","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.biopha.2026.119250_bib41","first-page":"A306","article-title":"Role of soluble TGF-beta and VEGF in ovarian cancer progression","volume":"34","author":"Boujelbene","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.biopha.2026.119250_bib42","first-page":"159","article-title":"The challenges and prospects of p53-based therapies in ovarian cancer","volume":"13","author":"Wallis","year":"2023","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.biopha.2026.119250_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2024.100981","article-title":"Retrospective analysis of prognostic and predictive significance of Ki-67 And P53 in treated primary advanced epithelial ovarian cancer.","volume":"35","author":"Banthia","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.biopha.2026.119250_bib44","first-page":"1419","article-title":"High Ki-67 expression is significantly associated with poor prognosis of ovarian cancer patients: evidence from a meta-analysis","volume":"299","author":"Qiu Dongmei","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.biopha.2026.119250_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106020","article-title":"Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer","volume":"26","author":"Glassman","year":"2023","journal-title":"iScience"}],"updated-by":[{"DOI":"10.1016\/j.biopha.2026.119519","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000}},{"DOI":"10.1016\/j.biopha.2026.119519","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226002830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226002830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T19:59:05Z","timestamp":1780862345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226002830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":45,"alternative-id":["S0753332226002830"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119250","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticancer effects of salidroside on ovarian cancer carcinogenesis and molecular mechanism in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119250"}}